Dashboard
Manage Tickers

AFMDAffimed N.V.

Nasdaq affimed.com


$ 5.07 $ 0.15 (3.07 %)    

Friday, 26-Apr-2024 15:59:29 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 5.03
$ 4.71
$ 0.00 x 0
$ 0.00 x 0
$ 4.71 - $ 5.07
$ 2.24 - $ 11.10
48,580
na
76.59M
$ 1.18
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

affimed-announces-acceptance-of-afm24-clinical-abstract-for-egfr-wildtype-egfrwt-non-small-cell-lung-cancer-nsclc-at-the-2024-annual-meeting-of-the-american-society-of-clinical-oncology
Affimed Announces Acceptance of AFM24 Clin...
04/24/2024 08:08:34

wells-fargo-maintains-overweight-on-affimed-lowers-price-target-to-25
Wells Fargo Maintains Overweight on Affime...
04/01/2024 15:37:33

Wells Fargo analyst Yanan Zhu maintains Affimed (NASDAQ:AFMD) with a Overweight and lowers the price target from $30 to $25.

cantor-fitzgerald-reiterates-overweight-on-affimed
Cantor Fitzgerald Reiterates Overweight on...
04/01/2024 15:15:20

Cantor Fitzgerald analyst Li Watsek reiterates Affimed (NASDAQ:AFMD) with a Overweight.

hc-wainwright--co-maintains-buy-on-affimed-raises-price-target-to-10
HC Wainwright & Co. Maintains Buy on Affim...
04/01/2024 10:36:11

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Affimed (NASDAQ:AFMD) with a Buy and raises the price targe...

affimed-q4-eps-150-beats-167-estimate-sales-44455k-miss-170m-estimate
Affimed Q4 EPS $(1.50) Beats $(1.67) Estim...
03/28/2024 12:25:02

Affimed (NASDAQ:AFMD) reported quarterly losses of $(1.50) per share which beat the analyst consensus estimate of $(1.67) by 10...

affimed-fy2023-eps-709-down-from-604-yoy-sales-891m-down-from-4135m-yoy-cash-cash-equivalents-and-investments-of-72m-provide-cash-runway-into-2h-2025
Affimed FY2023 EPS €(7.09) Down From €(6.0...
03/28/2024 10:43:34

earnings-scheduled-for-march-28-2024
Earnings Scheduled For March 28, 2024
03/28/2024 09:24:44

Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per ...

a-preview-of-affimeds-earnings
A Preview Of Affimed's Earnings
03/27/2024 15:01:07

affimed-nv-shares-resume-trade
Affimed N.V. Shares Resume Trade
03/11/2024 13:00:28

trading-halt-halt-status-updated-at-85500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:55:...
03/11/2024 12:55:04

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
03/09/2024 00:50:04

why-united-natural-foods-shares-are-trading-lower-by-15-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why United Natural Foods Shares Are Tradin...
03/06/2024 18:54:52

Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results.

affimed-announces-1-for-10-reverse-stock-split
Affimed Announces 1-for-10 Reverse Stock S...
03/06/2024 11:41:45

The reverse stock split is expected to be effected after market close on March 8, 2024, with the Common Shares expected to begi...

affimed-provides-clinical-response-update-on-afm24-102-trial-in-egfr-wildtype-non-small-cell-lung-cancer
Affimed Provides Clinical Response Update ...
01/08/2024 21:16:09

Data update from AFM24-102 Phase 1/2a combination study includes 15 heavily pre-treated patients from the EGFR-wildtype (wt) no...

affimed-confirms-guidance-on-data-readouts-for-afm24-102-and--luminice-203-in-h1-2024
Affimed Confirms Guidance On Data Readouts...
01/08/2024 13:29:57

affimed-announces-leadership-change-and-organizational-restructuring-dr-adi-hoess-to-step-down-as-ceo-and-management-board-member-dr-andreas-harstrick-appointed-interim-ceo-strategic-restructuring-reducing-headcount-by-up-to-50
Affimed Announces Leadership Change And Or...
01/08/2024 13:29:21

Dr. Adi Hoess to step down as CEO and Management Board MemberDr. Andreas Harstrick appointed Interim CEOStrategic restructuring...

why-resources-connection-shares-are-trading-higher-by-over-6-here-are-20-stocks-moving-premarket
Why Resources Connection Shares Are Tradin...
01/04/2024 12:59:32

Shares of Resources Connection, Inc. (NASDAQ: RGP) rose sharply in pre-market trading following better-than-expected results f...

affimed-announces-sale-of-wholly-owned-subsidiary-abcheck-for-6m
Affimed Announces Sale Of Wholly-Owned Sub...
01/03/2024 11:35:19

affimed-announces-data-for-afm24-in-combination-with-atezolizumab-in-heavily-pre-treated-egfr-wildtype-non-small-cell-lung-cancer-patients
Affimed Announces Data for AFM24 in Combin...
12/11/2023 11:03:33

affimed-announced-updated-data-on-its-lead-innate-cell-engager-acimtamig-in-combination-with-allogeneic-nk-in-hodgkin-lymphoma-patients-who-failed-prior-chemotherapy-and-are-double-refractory-to-brentuximab-vedotin-and-checkpoint-inhibitors
Affimed Announced Updated Data On Its Lead...
12/11/2023 11:02:10

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION